MRSASelect II
Dec 2017
262d
VRESELECT CULTURE MEDIUM
Nov 2012
105d
VRESELECT CULTURE MEDIUM
Oct 2011
308d
PLATELIA ASPERGILLUS EIA MODEL 62793
Jan 2011
412d
MRSA SELECT - SKIN AND SOFT TISSUE WOUND SPECIMENS
Oct 2010
241d
PLATELIA LYME IGM
Jun 2008
42d
MRSASELECT - EXTENDED INCUBATION
Jun 2008
45d
PLATELIA LYME IGG ASSAY
May 2008
126d
MRSASELECT
Sep 2007
218d
PLATELIA ASPERGILLUS EIA, MODEL 62793
Jun 2006
84d
LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4
Nov 2005
33d
LIQUICHEK QUALITATIVE URINE TOXICOLOGY CONTROL, NEGATIVE, POSITIVE, MINIPAK
Aug 2005
11d
LIQUICHEK CARDIAC MARKERS PLUS CONTROL, LIQUICHEK CARDIAC MARKERS PLUS CONTROL LT, LIQUICHEK CARDIAC MARKERS PLUS
Apr 2005
56d
QUEST DIAGNOSTICS IMMUNOASSAY/TDM CONTROL
Mar 2005
22d
LIQUID ASSAYED MULTIQUAL CONTROL
Jan 2005
49d
LIQUICHEK URINE TOXICOLOGY CONTROL, (LEVELS S1S AND S2S)
Nov 2004
37d
QUEST TUMOR MARKER CONTROL, MODEL 955
Nov 2004
24d
LIQUICHEK RETICULOCYTE CONTROL (A)
Nov 2004
22d
LIQUICHEK ELEVATED CRP CONTROL
Nov 2004
19d
LYPHOCHEK ELEVATED IMMUNOSUPPRESSANT CONTROL, LEVEL 4, 5
Oct 2004
41d
LIQUICHEK WHOLE BLOOD VOLATILES CONTROL
Jul 2004
26d
LIQUICHEK HEMATOLOGY CONTROL (A)
Jun 2004
27d
LYPHOCHEK HEMOSTASIS CONTROL
Feb 2004
22d
LIQUICHEK QUALITATIVE URINE TOXICOLOGY CONTROL, NEGATIVE, MODEL 454; POSITIVE, MODEL 455
Dec 2003
52d
LIQUICHEK URINE TOXICOLOGY CONTROL (CONFIRMATORY SERIES)
Dec 2003
49d